Marine Divincenzo, Author at BioWin

Qualiblood

QUALIblood is a contract research organization aiming to provide the industries, hospitals, and universities with all analytical services for human biofluid investigations and hemocompatibility testing. We offer tailor-made solutions, from the design of analytical protocols up to the development and validation of specific analytical methods. We propose the management of...

Marine Divincenzo In A, Service provider

Vivactis HM3A

Vivactis HM3A is a consultancy agency specialized in market access and health economics for pharmaceuticals, biotechnological products, medical devices and digital health, diagnostics, vaccines, and nutrinomics. The Vivactis group offers an international coverage. Our Market Access Services can support your EU and international market launches. We have access to highly...

Marine Divincenzo In Blogs

The MoveUp Program is back for a 6th edition!

Corporate companies: join the program! E-health startups → call opens August 25th Digital Attraxion’s MoveUp Program is a 20 weeks acceleration program based in the heart of Europe. It is directed to startups from around Europe who are looking to target the European Market. For this 6th edition, which will...

Marine Divincenzo In Full Member, T

Telix

Our purpose is to help people with cancer and rare diseases live longer, better quality lives. Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic (‘theranostic’) products using molecularly targeted radiation (MTR). Telix’s research pipeline aims to address significant unmet medical need in prostate, kidney, brain (glioblastoma), and hematologic cancers as...

Marine Divincenzo In Full Member

ABL

From development to market ABL provides GMP viral vectors, contributing to the success of client’s immunotherapy innovations. ABL, leader and pioneer in the development and manufacturing of viral vectors. Our main activities : Process development Manufacturing GMP/BPF Qualification Validation Quality Assurance Quality Control Our products are mainly used in clinical trials...

Marine Divincenzo In Membership, Service provider, Z

Zorgi

ZORGI is the result of the integration between Xperthis and Infohos Solutions, two Belgian specialists in IT solutions for the healthcare sector. ZORGI supports hospitals in their digital transformation by offering solutions for all milestones of the hospital care chain: from patient admission to billing, care and support, pharmacy, logistics,...

Marine Divincenzo In Active, Regional

Vetphage

This project was conceived on the basis of the important economic and sanitary impacts related to bovine mastitis in dairy production as well as on the basis of the restrictions on the use of antibiotics as a means of treatment of this pathology. Its objective is the development of phage-based...

Marine Divincenzo In Active, Regional

SoftMed

Numerous studies have shown that the majority of medical errors are attributable to a problem of non-technical skills (communication and teamwork) rather than a lack of technical skills. However, most of the training and tools used in these studies are aimed at the acquisition of technical skills only. The SoftMed...

Marine Divincenzo In Active, Active, Regional

NEMO

In the biopharmaceutical sector, the development of bio-processes requires significant investments in time and resources: these processes are generally obtained after numerous iterations aimed at determining the operational parameters and measurements allowing to characterize them. The NEMO project aims to support the development of these bio-processes through digital technologies: it...

Marine Divincenzo In Active, Project Type, Regional

AEROVID

In order to improve the effectiveness of inhalation therapy and prevent the increasing prevalence of respiratory disease exacerbations, Aquilon (AQ) and Radiomics (RDX), together with the academic partners ULiège, ULB and UMONS (A.E., Academic Entities of the consortium) have decided to join their respective competences in the AEROVID project. The...